ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysis
Cochrane Database of Systematic Reviews
◽
10.1002/14651858.cd013798
◽
2020
◽
Author(s):
Marius Goldkuhle
◽
Angela Aldin
◽
Tina Jakob
◽
Anne Adams
◽
Ina Monsef
◽
...
Keyword(s):
Systematic Review
◽
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Meta Analysis
◽
Advanced Renal Cell Carcinoma
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Related Documents
Cited By
References
Comparative Efficacy, Safety, and Costs of Sorafenib vs. Sunitinib as First-Line Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
Frontiers in Oncology
◽
10.3389/fonc.2019.00479
◽
2019
◽
Vol 9
◽
Cited By ~ 3
Author(s):
Huan Deng
◽
Wenfeng Liu
◽
Ting He
◽
Zhengdong Hong
◽
Fengming Yi
◽
...
Keyword(s):
Systematic Review
◽
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Meta Analysis
◽
Comparative Efficacy
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
First-line treatment in the management of advanced renal cell carcinoma: systematic review and network meta-analysis
Expert Opinion on Pharmacotherapy
◽
10.1517/14656566.2015.1058359
◽
2015
◽
Vol 16
(13)
◽
pp. 1915-1927
◽
Cited By ~ 15
Author(s):
James Larkin
◽
Abby Paine
◽
Grace Foley
◽
Stephen Mitchell
◽
Connie Chen
Keyword(s):
Systematic Review
◽
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Meta Analysis
◽
Advanced Renal Cell Carcinoma
◽
Line Treatment
◽
First Line
◽
First Line Treatment
Download Full-text
PCASE1 UTILIZING EVIDENCE FROM DIFFERENT LEVELS IN THE REIMBURSEMENT PROCESS OF NEW MEDICAL TECHNOLOGIES-ADVANCED RENAL CELL CARCINOMA FIRST LINE THERAPY IN POLAND 2008-2009
Value in Health
◽
10.1016/s1098-3015(10)73062-x
◽
2010
◽
Vol 13
(3)
◽
pp. A217
Author(s):
W Matusewicz
◽
J Baran
◽
MM Farkowski
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Advanced Renal Cell Carcinoma
◽
First Line
◽
Medical Technologies
◽
First Line Therapy
◽
Line Therapy
◽
Different Levels
Download Full-text
Cost-effectiveness of nivolumab plus ipilimumab as first-line therapy in advanced renal-cell carcinoma
Journal for ImmunoTherapy of Cancer
◽
10.1186/s40425-018-0440-9
◽
2018
◽
Vol 6
(1)
◽
Cited By ~ 20
Author(s):
Bin Wu
◽
Qiang Zhang
◽
Jie Sun
Keyword(s):
Renal Cell Carcinoma
◽
Cost Effectiveness
◽
Cell Carcinoma
◽
Renal Cell
◽
Advanced Renal Cell Carcinoma
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
The European Commission has granted approval for temsirolimus [Torisel; Wyeth Pharmaceuticals] within the EU as first-line therapy in patients with advanced renal cell carcinoma
Inpharma Weekly
◽
10.2165/00128413-200716160-00065
◽
2007
◽
Vol &NA;
(1616)
◽
pp. 27
Author(s):
&NA;
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
European Commission
◽
Renal Cell
◽
Advanced Renal Cell Carcinoma
◽
First Line
◽
First Line Therapy
◽
Line Therapy
◽
The Eu
Download Full-text
Phase II study of pazopanib plus interferon alfa as first-line therapy of advanced renal cell carcinoma: A Spanish Oncology Genitourinary Group (SOGUG) study.
Journal of Clinical Oncology
◽
10.1200/jco.2016.34.15_suppl.4571
◽
2016
◽
Vol 34
(15_suppl)
◽
pp. 4571-4571
Author(s):
Xavier Garcia del Muro
◽
Miguel Angel Climent
◽
Jose Luis Perez-Gracia
◽
Begona Mellado
◽
JA Virizuela
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Renal Cell
◽
Phase Ii Study
◽
Interferon Alfa
◽
Advanced Renal Cell Carcinoma
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
P0211 EVERSUN: A phase 2 trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (ANZUP Trial 0901)
European Journal of Cancer
◽
10.1016/j.ejca.2014.03.255
◽
2014
◽
Vol 50
◽
pp. e68-e69
Author(s):
I.D. Davis
◽
A. Long
◽
A. Martin
◽
D. Espinoza
◽
S. Yip
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Advanced Renal Cell Carcinoma
◽
Phase 2
◽
First Line
◽
First Line Therapy
◽
Phase 2 Trial
◽
Line Therapy
Download Full-text
7154 POSTER Hypothyroidism and Macrocytosis as Surrogate Markers for Response and Survival in Patients With Advanced Renal Cell Carcinoma Treated With Sunitinib as First-line Therapy
European Journal of Cancer
◽
10.1016/s0959-8049(11)72069-x
◽
2011
◽
Vol 47
◽
pp. S521
◽
Cited By ~ 1
Author(s):
A. Pinto
◽
V. Moreno
◽
C. Aguayo
◽
M. Garrido
◽
E. Espinosa
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Advanced Renal Cell Carcinoma
◽
Surrogate Markers
◽
First Line
◽
First Line Therapy
◽
Line Therapy
Download Full-text
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma
Annals of Oncology
◽
10.1093/annonc/mdv078
◽
2015
◽
Vol 26
(6)
◽
pp. 1118-1123
◽
Cited By ~ 6
Author(s):
I.D. Davis
◽
A. Long
◽
S. Yip
◽
D. Espinoza
◽
J.F. Thompson
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Advanced Renal Cell Carcinoma
◽
Phase 2
◽
First Line
◽
First Line Therapy
◽
Phase 2 Trial
◽
Line Therapy
Download Full-text
First line antiangiogenics for advanced renal cell carcinoma: A systematic review and network meta-analysis comparing efficacy and toxicities.
Journal of Clinical Oncology
◽
10.1200/jco.2015.33.15_suppl.e15586
◽
2015
◽
Vol 33
(15_suppl)
◽
pp. e15586-e15586
Author(s):
Emmanuelle Kempf
◽
Benoit Rousseau
◽
Gaelle Desamericq
◽
Emilie Boissier
◽
Charlotte Joly
◽
...
Keyword(s):
Systematic Review
◽
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Renal Cell
◽
Meta Analysis
◽
Advanced Renal Cell Carcinoma
◽
First Line
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close